Clinical analysis of 62 cases of treatment of pediatric upper respiratory tract infection
Objective To investigate the clinical effect of treatment of pediatric upper respiratory tract infection. Methods Retrospective analysis of the clinical data of the treatment of children in our hospital from 2013 October of 62 cases of children with acute upper respiratory tract infection in 2012 to January, and compared with ribavirin therapy in 62 cases of children with acute upper respiratory tract infection with the same. Treatment effects were compared between the two groups. Results observation treatment group total effectiveness 95.16%, control group was 75.81%, total effective treatment observation group was obviously higher than that of control group, the difference was statistical y significant (P < 0.05). Two groups before and after treatment in children with liver and kidney function, blood in urine routine has no obvious change, no other serious adverse reactions. Conclusion inflammation Hu safety, efficacy significantly better in treatment of children acute upper respiratory tract infection, can significantly improve the clinical symptoms, shorten the course of the disease, prevent complications, worthy of clinical popularization and application.
children with upper respiratory tract infection inflammationHu ning